Ovádi Judit, Orosz Ferenc, Hollán Susan
Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary.
Mol Cell Biochem. 2004 Jan-Feb;256-257(1-2):83-93. doi: 10.1023/b:mcbi.0000009860.86969.72.
Research in the last 10 years has revealed that the development of neurodegeneration is a multistep process during which one or few specific mutant protein species of altered conformation initiate aberrant protein-protein interactions resulting in aggregates forming plaques. This review focuses on the heteroassociations of the mutant proteins with subcellular structures, such as cytoskeleton, cell membranes or with glycolytic enzymes, which may be crucial in the initiation of neurodegeneration such as in Huntington's disease or Alzheimer's disease. Triosephosphate isomerase enzymopathy is a unique glycolytic enzyme deficiency coupled with neurodegeneration. We present data on the mutation induced misfolding process, which likely plays a crucial role in the enhanced associations of the enzyme with the truncated fragment of the isomerase, with the red cell membrane or with the microtubular network. On the basis of our recent clinical and experimental results obtained with two compound heterozygote Hungarian brothers it became obvious that the mutations alone are not sufficient to explain the development of the neurological sympthomes. This underscores the fact that the mutations alone are not enough for the development of the clinical phenotype of a disease.
过去10年的研究表明,神经退行性变的发展是一个多步骤过程,在此过程中,一种或几种构象改变的特定突变蛋白物种引发异常的蛋白质-蛋白质相互作用,导致聚集体形成斑块。本综述聚焦于突变蛋白与亚细胞结构(如细胞骨架、细胞膜)或糖酵解酶的异源缔合,这在神经退行性变(如亨廷顿舞蹈症或阿尔茨海默病)的起始过程中可能至关重要。磷酸丙糖异构酶病是一种独特的糖酵解酶缺乏症并伴有神经退行性变。我们展示了关于突变诱导的错误折叠过程的数据,该过程可能在该酶与异构酶截短片段、红细胞膜或微管网络的增强缔合中起关键作用。基于我们最近对两名复合杂合子匈牙利兄弟的临床和实验结果,很明显仅突变不足以解释神经症状的发展。这突出了一个事实,即仅突变不足以导致疾病临床表型的发展。